🇺🇸 FDA
Pipeline program

SIS-reinforced anastomosis

2025-科-689

Approved other active

Quick answer

SIS-reinforced anastomosis for Rectal Cancer is a Approved program (other) at Rocket Pharmaceuticals B.V. with 1 ClinicalTrials.gov record(s).

Program details

Company
Rocket Pharmaceuticals B.V.
Indication
Rectal Cancer
Phase
Approved
Modality
other
Status
active

Clinical trials